Mek ICS Corrects Proxy Filing to Include Business Expansion in Charter Amendment Agenda
Mek ICS issued a correction on Oct. 15, 2026, clarifying that proposed charter amendments include adding in vitro diagnostic device manufacturing. The proposed business expansion aims to generate additional manufacturing revenue; shareholders will vote on Oct. 30, 2026. Disclaimer: This news brief was created by Public